While the Tampa Bay Buccaneers are the team to beat in the NFC South, a division rival made a move of their own. The Atlanta Falcons signed quarterback Easton Stick, the team announced today.

SAN FRANCISCO — X rival Bluesky on Monday said it was adding blue checks to accounts that have been verified to confirm users are who they claim to be. In a blog post, the company said it would ...

The move mirrors a feature once deployed at Twitter. X rival Bluesky on Monday said it was adding blue checks to accounts that have been verified to confirm users are who they claim to be.

The New York Yankees need some help at the hot corner. Perhaps DJ LeMahieu can provide that when he returns from injury, but his continual stints on the injured list makes it hard for the team to ...

Despite what many New England Patriot radio reporters believe, A.J. Brown is not heading to the AFC East to take on the Buffalo Bills this draft cycle. The Buffalo Bills know they have the ...

Panthers general manager Dan Morgan addressed the media before the 2025 NFL Draft last week. One of the biggest questions before Carolina enters the first round on Thursday night is do they have ...

While the average basketball fan may not have been familiar with Chennedy Carter heading into last WNBA season, she quickly changed that in a game against the Indiana Fever. The former Chicago ...

Sky might be top dog when it comes to premium TV, but it is facing some stiff competition from a relative newcomer. Freely launched last year and, just like Sky's latest streaming devices, it ...

Troy Deeney was dismissed for a reckless shove as his Baller League debut ended in disaster. The former Watford star, who has not played competitively since leaving Forest Green Rovers last year ...

At least not according to a rival of the Ravens, Andrew Berry, general manager of the Cleveland Browns. Berry spoke with reporters on Thursday, April 17 and named the draft QB who could surpass ...

is widely regarded as one of the best 2D fighting games of all time and a close rival to contemporary Street Fighter 3. The subtitle to this belated sequel is clearly meant to be reminiscent of ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...